Science | ABNewswire

PITAKA Turns the Galaxy S26 Case Into a Programmable Control Hub With Aaron Button

Hong Kong, China – 25th Feb, 2026 – PITAKA today introduces its Galaxy S26 case lineup featuring the Aaron Button, a built-in three-button shortcut system that transforms a traditional phone case into an intelligent hardware interface. Designed for productivity and customization, … Continue reading →

Redefining Range Safety: Why Tactical Trauma Kits Are the New Standard for Shooters and Hunters

Standard first aid fails in ballistic trauma. Discover Rhino Rescue’s military-grade IFAKs, designed for zero-hesitation hemorrhage control in the backcountry. The responsible firearm ownership culture is based on safety and preparedness. Nevertheless, as contemporary shooters and hunters spend a lot … Continue reading →

Codex Labs to Attend Health.tech Global Summit to Advance Root Cause Dermatology Innovation

BASEL, Switzerland – February 24, 2026 – Codex Labs, a biotech skincare company focused on integrative dermatology and microbiome-friendly skin-gut solutions, is honored to participate in the health.tech global summit. The world’s top innovators, decision-makers and leaders will gather at … Continue reading →

Hepatic Tumor Clinical Trial Pipeline Expands as 75+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s, “Hepatic Tumor Pipeline Insight 2026”report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in Hepatic Tumor pipeline landscape. It covers the Hepatic Tumor pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Hepatic … Continue reading →

Head and Neck Cancer Clinical Trial Pipeline Gains Momentum: 80+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Head and Neck Cancer Pipeline Insight 2026” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Head and Neck Cancer pipeline landscape. It covers the Head and Neck Cancer Pipeline drug profiles, including clinical and … Continue reading →

Esophageal Cancer Clinical Trial Pipeline Accelerates as 80+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight, “Esophageal Cancer Pipeline Insight 2026” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Esophageal Cancer pipeline landscape. It covers the Esophageal Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Duchenne Muscular Dystrophy Clinical Trial Pipeline Gains Momentum: 75+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Duchenne Muscular Dystrophy Pipeline Insight 2026” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Duchenne Muscular Dystrophy pipeline landscape. It covers the Duchenne Muscular Dystrophy pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Dry AMD Clinical Trial Pipeline Gains Momentum: 70+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Dry Age-related Macular Degeneration Pipeline Insight, 2026” report provides comprehensive insights about 70+ companies and 80+ pipeline drugs in Dry Age-related Macular Degeneration (Dry-AMD) pipeline landscape. It covers the Dry Age-Related Macular Degeneration pipeline drug profiles, including clinical and … Continue reading →

Diffuse Large B-Cell Lymphoma Clinical Trial Pipeline Accelerates as 70+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Diffuse Large B-Cell Lymphoma Pipeline Insights 2026” report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Diffuse Large B-Cell Lymphoma pipeline landscape. It covers the Diffuse Large B-Cell Lymphoma pipeline drug profiles, including clinical and nonclinical … Continue reading →

Metastatic Hormone Refractory Prostate Cancer Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Metastatic Hormone Refractory Prostate Cancer Pipeline Insight 2026” report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in the Metastatic Hormone Refractory Prostate Cancer pipeline landscape. It covers the Metastatic Hormone Refractory Prostate Cancer Pipeline drug profiles, … Continue reading →

Thursday - September 24, 2026

Category Archives: Science